カテゴリ： IMARC, 世界, 医療/バイオ

泌尿生殖器治療薬のグローバル市場：前立腺癌、卵巣癌、膀胱癌、子宮頸癌、その他

■ 英語タイトル：Genitourinary Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23DCB0272）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23DCB0272
■ 発行日：2023年11月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：144
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[泌尿生殖器治療薬のグローバル市場：前立腺癌、卵巣癌、膀胱癌、子宮頸癌、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界の泌尿生殖器治療薬市場規模は2022年に324億ドルに達しました。今後、IMARC Groupは、市場は2028年までに370億ドルに達し、2022〜2028年の成長率（CAGR）は2.2%になると予測しています。
泌尿生殖器系には、腎臓、尿管、膀胱、尿道、生殖器などが含まれ、生殖や体内の老廃物の排出に重要な役割を果たしています。その機能は、先天異常、異所性損傷、癌、外傷、感染症、水腎症、炎症などの理由で阻害されることがあります。このような疾病に罹患する患者数が増加しているため、泌尿生殖器治療薬の需要は世界中で増加しています。泌尿生殖器治療薬は、生殖器官、排泄系、尿路系疾患の治療に役立つ。また、膀胱けいれんや勃起不全の治療、早産予防のための子宮収縮抑制にも使用されます。

泌尿生殖器治療薬の市場動向
泌尿生殖器障害のリスク増大は、市場の成長に影響を与える主な要因の1つです。また、泌尿生殖器治療薬は慢性腎不全や尿路感染症を患う小児患者の治療に有効であるため、世界中で売上が増加しています。これとは別に、市場の大手企業は、従来の化学療法剤やホルモン療法剤に耐性を獲得した慢性前立腺がん患者の治療に役立つ薬剤を導入するため、製剤化技術の進歩に注力しています。さらに、いくつかの多国籍企業（MNC）は、次世代治療薬を上市し、市場での地位を強化するために、バイオ医薬品のリーダーと協力しています。これは、後期臨床試験段階にあるパイプライン医薬品の数が大幅に増加していることと相まって、市場の成長に寄与しています。このほか、研究開発（R&D）プロジェクトに対する資金提供の増加や、各国の政府機関や非政府機関が後援する医療インフラの改善も、今後数年間の泌尿生殖器治療薬の需要を押し上げると予想されます。

主要市場のセグメンテーション
IMARC Groupは、泌尿生殖器治療薬の世界市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、適応症と製品に基づいて市場を分類しています。

適応症別
前立腺がん
卵巣がん
膀胱がん
子宮頸がん
腎臓がん
勃起不全
尿路感染症
尿失禁と過活動膀胱
性感染症
間質性膀胱炎
血尿
前立腺肥大症

製品別
泌尿器科領域
ホルモン療法
婦人科
抗感染症薬
その他

地域別
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争環境
業界の競争環境は、Allergan plc（AbbVie Inc）、Antares Pharma Inc、AstraZeneca plc、Bayer AG、Bristol-Myers Squibb Company、Genentech Inc（Roche Holding AG）、GlaxoSmithKline plc、Merck & Co. Inc.、Novartis AG、Pfizer Inc.、Teva Pharmaceutical Industries Ltd.など。

本レポートで扱う主な質問
1. 泌尿生殖器治療薬の世界市場規模は？
2. 2023-2028年における泌尿生殖器治療薬の世界市場成長率は？
3. 泌尿生殖器治療薬の世界市場を牽引する主な要因は？
4. COVID-19が泌尿生殖器治療薬の世界市場に与えた影響は？
5. 泌尿生殖器治療薬の世界市場における適応症別の内訳は？
6. 泌尿生殖器治療薬世界市場の製品別内訳は？
7. 泌尿生殖器治療薬の世界市場における主要地域は？
8. 泌尿生殖器治療薬の世界市場における主要プレイヤー/企業は？

1. 序論
2. 範囲・調査手法
3. エグゼクティブサマリー
4. イントロダクション
5. 世界の泌尿生殖器治療薬市場
6. 泌尿生殖器治療薬の世界市場規模：疾患別
7. 泌尿生殖器治療薬の世界市場規模：製品別
8. 泌尿生殖器治療薬の世界市場規模：地域別
9. SWOT分析
10. バリューチェーン分析
11. ファイブフォース分析
12. 価格分析
13. 競争状況

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Genitourinary Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 Prostate Cancer
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ovarian Cancer
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Bladder Cancer
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Cervical Cancer
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Renal Cancer
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Erectile Dysfunction
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Urinary Tract Infections
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Urinary Incontinence and Overactive Bladder
6.8.1 Market Trends
6.8.2 Market Forecast
6.9 Sexually Transmitted Diseases
6.9.1 Market Trends
6.9.2 Market Forecast
6.10 Interstitial Cystitis
6.10.1 Market Trends
6.10.2 Market Forecast
6.11 Hematuria
6.11.1 Market Trends
6.11.2 Market Forecast
6.12 Benign Prostatic Hyperplasia
6.12.1 Market Trends
6.12.2 Market Forecast
7 Market Breakup by Product
7.1 Urological
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Hormonal Therapy
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Gynecological
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Anti-infectives
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 Allergan plc (AbbVie Inc.)
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 SWOT Analysis
13.3.2 Antares Pharma Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.3 AstraZeneca plc
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.4 Bayer AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Bristol-Myers Squibb Company
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis
13.3.6 Genentech Inc. (Roche Holding AG)
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 SWOT Analysis
13.3.7 GlaxoSmithKline plc
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Financials
13.3.7.4 SWOT Analysis
13.3.8 Merck & Co. Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Financials
13.3.8.4 SWOT Analysis
13.3.9 Novartis AG
13.3.9.1 Company Overview
13.3.9.2 Product Portfolio
13.3.9.3 Financials
13.3.9.4 SWOT Analysis
13.3.10 Pfizer Inc.
13.3.10.1 Company Overview
13.3.10.2 Product Portfolio
13.3.10.3 Financials
13.3.10.4 SWOT Analysis
13.3.11 Teva Pharmaceutical Industries Ltd.
13.3.11.1 Company Overview
13.3.11.2 Product Portfolio
13.3.11.3 Financials

Figure 1: Global: Genitourinary Drugs Market: Major Drivers and Challenges
Figure 2: Global: Genitourinary Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Genitourinary Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Genitourinary Drugs Market: Breakup by Indication (in %), 2022
Figure 5: Global: Genitourinary Drugs Market: Breakup by Product (in %), 2022
Figure 6: Global: Genitourinary Drugs Market: Breakup by Region (in %), 2022
Figure 7: Global: Genitourinary Drugs (Prostate Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Genitourinary Drugs (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Genitourinary Drugs (Ovarian Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Genitourinary Drugs (Ovarian Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Genitourinary Drugs (Bladder Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Genitourinary Drugs (Bladder Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Genitourinary Drugs (Cervical Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Genitourinary Drugs (Cervical Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Genitourinary Drugs (Renal Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Genitourinary Drugs (Renal Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Genitourinary Drugs (Erectile Dysfunction) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Genitourinary Drugs (Erectile Dysfunction) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Genitourinary Drugs (Urinary Tract Infections) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Genitourinary Drugs (Urinary Tract Infections) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Genitourinary Drugs (Urinary Incontinence and Overactive Bladder) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Genitourinary Drugs (Sexually Transmitted Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Genitourinary Drugs (Interstitial Cystitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Genitourinary Drugs (Interstitial Cystitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Genitourinary Drugs (Hematuria) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Genitourinary Drugs (Hematuria) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Genitourinary Drugs (Benign Prostatic Hyperplasia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: Genitourinary Drugs (Urological) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: Genitourinary Drugs (Urological) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: Genitourinary Drugs (Hormonal Therapy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: Genitourinary Drugs (Hormonal Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: Genitourinary Drugs (Gynecological) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: Genitourinary Drugs (Gynecological) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: Genitourinary Drugs (Anti-infectives) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: Genitourinary Drugs (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: Genitourinary Drugs (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: Genitourinary Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: North America: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: North America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: United States: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: United States: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: Canada: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: Canada: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Asia-Pacific: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Asia-Pacific: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: China: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: China: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Japan: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Japan: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: India: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: India: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: South Korea: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: South Korea: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: Australia: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: Australia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: Indonesia: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: Indonesia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Europe: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Europe: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Germany: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Germany: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: France: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: France: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: United Kingdom: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: United Kingdom: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Italy: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Italy: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Spain: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Spain: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Russia: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Russia: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Latin America: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Latin America: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Brazil: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Brazil: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Mexico: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Mexico: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Others: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Others: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Middle East and Africa: Genitourinary Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Middle East and Africa: Genitourinary Drugs Market: Breakup by Country (in %), 2022
Figure 89: Middle East and Africa: Genitourinary Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Global: Genitourinary Drugs Industry: SWOT Analysis
Figure 91: Global: Genitourinary Drugs Industry: Value Chain Analysis
Figure 92: Global: Genitourinary Drugs Industry: Porter's Five Forces Analysis

Table 1: Global: Genitourinary Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Genitourinary Drugs Market Forecast: Breakup by Indication (in Million US$), 2023-2028
Table 3: Global: Genitourinary Drugs Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 4: Global: Genitourinary Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Genitourinary Drugs Market: Competitive Structure
Table 6: Global: Genitourinary Drugs Market: Key Players

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • がん免疫療法の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23DCB0272 )"泌尿生殖器治療薬のグローバル市場：前立腺癌、卵巣癌、膀胱癌、子宮頸癌、その他" (英文：Genitourinary Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。